CLK inhibitor 2, with the CAS number 1005776-20-4, is a small molecule that functions as a selective inhibitor of the CLK (CDC2-like kinase) family of enzymes. These kinases play a crucial role in various cellular processes, including cell cycle regulation and RNA splicing. The compound is characterized by its ability to modulate alternative splicing of pre-mRNA, which can influence gene expression and protein diversity. CLK inhibitor 2 has been studied for its potential therapeutic applications, particularly in cancer and neurodegenerative diseases, where aberrant splicing is often observed. Its chemical structure typically includes specific functional groups that contribute to its binding affinity and selectivity for CLK enzymes. Additionally, the compound's pharmacokinetic properties, such as solubility and stability, are essential for its efficacy in biological systems. Research continues to explore its mechanisms of action and potential as a tool for understanding splicing regulation and developing novel treatments.

MDK6204, also know as CLK1/2-IN-2,  is a selective CLK1 and CLK2 inhibitor. MDK6204 has CAS

CLK inhibitor 2

1005776-20-4: CLK inhibitor 2, with the CAS number 1005776-20-4, is a small molecule that functions as a selective inhibitor of the CLK (CDC2-like kinase) family of enzymes. These kinases play a crucial role in various cellular processes, including cell cycle regulation and RNA splicing. The compound is characterized by its ability to modulate alternative splicing of pre-mRNA, which can influence gene expression and protein diversity. CLK inhibitor 2 has been studied for its potential therapeutic applications, particularly in cancer and neurodegenerative diseases, where aberrant splicing is often observed. Its chemical structure typically includes specific functional groups that contribute to its binding affinity and selectivity for CLK enzymes. Additionally, the compound's pharmacokinetic properties, such as solubility and stability, are essential for its efficacy in biological systems. Research continues to explore its mechanisms of action and potential as a tool for understanding splicing regulation and developing novel treatments.

MDK6204 is a selective inhibitor of CLK1 and CLK2.

CAS 1005776-20-4

CLK inhibitor 2

MDK6204

Ref: TM-T24439